Skip to main content
OpenTrials
Completed

NCT Number: NCT07412535

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dental Implant

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura University, Faculty of Dentistry

Al Mansurah, Egypt, 35516

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a maxillary anterior or premolar narrow ridge (width 3-6 mm), and adequate bone height (>8 mm), seeking horizontal augmentation & dental implant rehabilitation

Exclusion criteria

  • systemic contraindications to surgery, local infection, untreated periodontal disease, heavy smoking, or pregnancy.

Treatment and study plan

bovine bone mixed with hyaluronate

Combination Product

cerabone plus will be inserted as a graft material via subperiosteal tunneling of thin maxilla

bovine bone mixed with E-PEF

Combination Product

bovine bone mixed with E-PEF will be inserted as a graft material via subperiosteal tunneling of thin maxilla

Primary outcomes

  1. horizontal bone gain measurement

    Time frame: 6months, 12 months

    CBCT will be used to measure horizontal bone width of the surgical site (in mm) at 3 points: at level of the crest, 2 mm and 6mm apical to the crest.

Secondary outcomes

  1. bone density measurement

    Time frame: 6 months, 12 months

    Bone density will be assessed in HU by CBCT by using on demand 3D program

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Acronym: E-PRF

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Feb 17, 2026
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.